Marijuana Company of America, Inc. (MCOA) Provides Turnkey Services to Hemp Growers

Hemp cultivation in the U.S. is on the rise
33 U.S. states have dismantled barriers to hemp production
MCOA provides turnkey services to growers and distributors

Hemp is back! After a hiatus of 77 years, cultivation of hemp in the U.S. began again after the passage of the Farm Bill in 2014. The Farm Bill allows departments of agriculture and institutions of higher learning in states that have legalized hemp cultivation to grow hemp for research and pilot programs. Hemp grown for such purposes is now no longer subject to the provisions of the Controlled Substances Act (CSA), although, unfortunately, commercial cultivation still is. Despite the continued federal restriction on growing hemp, a majority of states (33) have dismantled barriers to hemp production, and U.S. hemp output doubled from 2016, with about 1,500 state hemp cultivation licenses being issued in 2017. These growers can turn to Marijuana Company of America, Inc. (OTC: MCOA) to get their enterprises off the ground. The company provides turnkey services to the legal cannabis and hemp industries. It also, through wholly owned subsidiary hempSMART™, delivers all of the benefits of hemp-derived cannabinoid (CBD) products to the world through its unique marketing and distribution platform.

The domestic network of hemp farmers and cultivars is set to expand as regulations ease. For example, research has shown that, instead of graphene, hemp bast fiber may be used in super-capacitor batteries to power electric vehicles (EVs) and handheld electric devices and tools. In addition, hemp fiber has long been a staple of housing construction in some cultures; now, it’s building American homes. Hemp houses are on the rise, as hempcrete, which is energy-efficient, non-toxic and resistant to mold, insects and fire, has many advantages over synthetic building materials, lumber and concrete. Hemp fiber can also be used to create environmentally friendly composites and hard bio-plastics for use in everything from airplanes to car parts.

Hemp seeds are also one of the fastest-growing categories in the natural foods industry. A rich source of Omega-3 and Omega-6 essential fatty acids (EFAs), these seeds provide both stearidonic acid (SDA) and gamma-linoleic acid (GLA), as well as naturally occurring vitamins and minerals, such as vitamin E and iron. Hemp seeds are also an excellent source of dietary fiber and a complete protein, containing all 10 essential amino acids with no enzyme inhibitors, which makes them more digestible by the human body.

Through wholly owned subsidiary hempSMART™, MCOA is bringing high quality CBD-based products derived from industrial hemp to market through its affiliate marketing program. Its patent-pending product, hempSMART Brain, provides safe and effective support of healthy brain function, while its recently launched HempSMART DROPS is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The company recently debuted its new encapsulate product, hempSMART Pain, formulated with 10mg of full spectrum, non-psychoactive CBD per serving, which, along with a proprietary blend of other natural ingredients, delivers an all-natural formulation for the temporary relief of minor pain associated with physical activity.

MCOA has also collaborated with the founders of HoneyB Healthy Living to develop Convenient Hemp Mart, LLC’s BeniHemp-branded products targeting convenience stores. The brand was officially launched at the recent ASD Market Week (March 11-14, 2018) business trade show in Las Vegas (http://cnw.fm/G74iX). Convenient Hemp Mart has developed a collection of Benihemp-branded, sample-sized products for consumers, including topicals, tinctures and edibles packaged in 1-day, 2-day, and 30-day supplies. The target markets for these offerings are convenience stores, smoke shops, gas stations and similar types of retail businesses where CBD commerce has a greater likelihood of generating sales from the impulse buyer at the register.

As legitimization of the hemp industry progresses, Marijuana Company of America has positioned itself at various points in the value chain. The company not only markets a wide range of hemp-derived CBD products; it also provides turnkey services for marketers and growers alike.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Compensation Disclosure

Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b), we are disclosing that we entered into a contract with Marijuana Company of America, Inc. The Company agreed to compensate us with $5,000 USD a month for our services.

Medical Cannabis Payment Solutions (REFG) Now Available To Entire Legal Cannabis Industry

REFG fully launched its payment system services to the entire industry
Technology is fully FinCEN-compliant
Bitcoin payments are on the horizon with Green

Medical Cannabis Payment Solutions (OTC: REFG) seeks to provide end-to-end management for medicinal marijuana operations. The company serves the medical cannabis and banking industries through state-of-the-art comprehensive card processing operations, and it has now fully launched its payment system services to the entire legal cannabis industry. The company previously worked only with targeted industry establishments, but its platform is now available to all state-sanctioned establishments in the U.S. and abroad. The company is the first of its kind, empowering cannabis businesses with an advanced client management system that tracks both sales and tax collection. REFG has solved the problem of banking and cashless payments within the cannabis industry.

The company offers electronic payment and e-commerce features that allow businesses direct and immediate access to funds. One of the advantages of using REFG’s top-tier digital payment processing system, Green, is its compliancy with FinCEN. The system tracks sales and tax collection while providing businesses with an advanced client management system. If a business is called on to prove compliance with financial regulations within the cannabis industry, the company cooperates with authorities and defends the client’s interests.

In addition, Green provides cannabis retailers and consumers with payment options other than cash. Consumers can purchase items using U.S. currency, and they will soon be allowed to pay with bitcoin. In November 2017, REFG announced that integration with First Bitcoin Capital’s Weed Coin cryptocurrency and StateSourced’s medical cannabis payment gateway services will soon enable cryptocurrency payments. This will increase the ease of payment and cash handling in the cannabis industry and will allow consumers to overcome many regulatory obstacles.

With growing trends toward widespread legalization, both in the U.S. and abroad, REFG is strategically positioned for growth as the only company on the market that’s currently offering a completely integrated payment processing system tailored to the cannabis industry.

For more information, visit the company’s website at www.MedicalCannabisPaymentSolutions.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Signs Deal to Open Multiple Choom™ Branded Retail Dispensaries

Choom™ is a high-quality hand-crafted cannabis brand created for the Canadian recreational market
Last month, the company opened retail opportunity to entrepreneurs and businesspeople across Canada
Choom™ inked first deal, not for just a single store, but rather for an entire territory

Set to be legalized in July of this year, Canada’s recreational marijuana market is estimated to exceed $8.7 billion annually. That figure doesn’t include ancillary businesses such as paraphernalia, weed-related tourism, testing labs and security services. All factored in, the market potential jumps to up to $22.6 billion a year (http://cnw.fm/h2lwW). The general consensus is that the marijuana market in Canada will only continue along an upward trajectory. Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is rapidly positioning itself to become the premier recreational cannabis brand in Canada and capture a significant portion of this newfound cannabis bonanza.

Choom™ is a high-quality hand-crafted cannabis brand created exclusively for the Canadian recreational market. By cultivating outstanding bud as well as an exceptional customer experience, Choom™ intends to become the recognized market leader in reaching the cannabis consumer. To achieve that end, Choom™ is developing a chain of modern, stylish dispensaries designed by the same team responsible for some of the most desirable retail environments in Canada. The company has expanded the opportunity to entrepreneurs and businesspeople interested in participating in the lucrative new recreational marijuana market by registering for their own Choom™ stores.

Announced only about a month ago (http://cnw.fm/QV1av), the response to owning a Choom™ store is exceeding expectations, as savvy business folks are lining up for a piece of the cannabis pie. This comes as little surprise, since legal recreational marijuana dispensaries are expected to generate more revenue per square foot than Whole Foods. In line with this response, the company recently announced that it has signed the first agreement in its retail investor program (http://cnw.fm/Er5eq).

Following its bold agenda, Choom™ has inked a deal not for just a single store but rather for an entire territory. A consortium of local investors and business partners known as the ‘Thompson Okanagan Choom Group’ has secured the exclusive territory rights to open multiple Choom™ branded retail dispensaries in the Thompson-Okanagan region. The Thompson-Okanagan region is a tourist magnet located in the central interior of British Columbia and offers wineries, boating and loads of outdoor activities. The investment consortium is led by Debra G. Adams, Sherman Dahl, Imre Kovacs and Kent Adams, all of whom are excited about the Choom™ opportunity. In a news release, Adams stated, “We’ve been closely monitoring the explosion of Cannabis companies in Canada and are very pleased to be working with a ‘best in class’ operator such as Choom™. The branding, professionalism and style of Choom™ is second to none and our team can’t wait to get started!”

By cultivating outstanding bud as well as an exceptional consumer experience, Choom™ is likely to attract evermore retail partners and is fast on its way to establishing a significant retail footprint and becoming a recognized leader in the Canadian recreational cannabis markets.

For more information, visit the company’s website at www.Choom.ca

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Seeking its Share in the Anticipated Canadian Recreational Marijuana Market

Potential Canadian marijuana market upside estimated at $22.6 billion
Choom™ strategy is soil-to-shelf integration through cultivation, branding and retail marketing
Company seeking phase 1 and 2 revenue growth in Vernon and Vancouver Island, British Columbia, Canada

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is focused on the recreational marijuana market in Canada and is projecting revenues from its retrofit and expansion efforts in Vernon and Vancouver Island, British Columbia, Canada. In its investor presentation of March 2018 (http://cnw.fm/pER7I), the company positioned itself to become a branded, fully integrated cannabis company in the recreational marijuana market of Canada. Its plans for growth include its own product cultivation, retail expansion and acquisitions.

In its presentation, Choom quotes the ‘Canaccord Genuity Canadian Cannabis Industry Overview’ as projecting that the total marijuana market will reach $6 billion by 2021. It finds that recreational users will outnumber medical marijuana users by almost eight times, calling for 3.8 million recreational users to roughly 500,000 medical users.

The Vancouver-based company is focused on branding, building a chain of its own Choom retail dispensaries, positioning its premium brand and acquiring production assets.

Choom has two significant projects. Through its presence in Vernon, British Columbia, it expects phase 1 revenue of $6.6 million, with $15 million from phase 2. A retrofit is scheduled for completion by July 2018, and expansion is planned for the end of 2018. In Vancouver Island, British Columbia, phase 1 potential revenue is estimated at $4.5 million, with $9 million in phase 2. All revenue projects exclude oils. Retrofit completion is scheduled for July 2018, and phase 2 expansion completion is planned by the end of 2019.

The larger picture focuses on the total marijuana market’s potential upside of $22.6 billion, according to the Deloitte Recreational Marijuana/Insights and Opportunities report (http://cnw.fm/ii5J6). This upside figure represents the additional revenue from growers, tourism, license fees, business taxes and base retail market value.

As it grows, Choom’s shares are now Depository Trust Company (“DTC”) of New York-eligible, allowing for easier trading of Choom shares on the OTC (http://cnw.fm/v72CO). The company recently named Chris Gagan as its senior vice president of marketing, making him responsible for the development of the Choom brand and retail marketing (http://cnw.fm/Nh6hM).

For more information, visit the company’s website at www.Choom.ca

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Nevada Eyes Denver’s New Pot Lounges, Las Vegas to Come to the Table in 2019

Denver presents the first recreational cannabis lounges
Las Vegas officials cautious about pot lounge endeavors until 2019 legislative meetings
Pilot projects in effect to weigh pros and cons of new recreational marijuana use

Denver’s first social-use marijuana permit was awarded to The Coffee Joint in early March of this year, establishing it as the first of what looks to be many pot consumption lounges to open in the coming years. Denver’s cannabis consumption establishment makes allowance for those who are over 21 to consume legal quantities of pot through methods of consuming edible products, vaping and dabbing within the venue itself, with the sole exclusion of smoking only being allowed outdoors (http://cnw.fm/YXa0Q).

City officials in Las Vegas are currently waiting on the City of Denver to approve the country’s first marijuana club, prior to their own discussions revolving around the licensing and regulation of lounges dedicated to marijuana within Las Vegas. With Nevada having permitted the lawful sale of recreational marijuana in July of 2017, a great demand has been placed on related commercial industries brought by the tourists that visit the state. The law mentions, however, that no public consumption of the substance is allowed outside of private residences.

In a public meeting following discussions around the opening of pot lounges, Commissioner James Gibson of Clark County, Nevada, said, “I don’t know if we need to be the first or not, I don’t see any reason why we have to be first, but we certainly have to be right.” Gibson went further to say that regardless of what happens, officials need to do their part and remain consistent through implementation of thorough procedures.

Denver’s announcement in August of 2017 allowed for the submission of applications by businesses that are looking to open marijuana clubs. Up until now, there have been few developments in this regard, with the slow start having been expected because of overly extensive application procedures. “What I have heard from the commission today is that they are open to the idea in concept, but they are not ready to move forward,” added Andrew Jolly, storeowner and president of the Nevada Dispensary Association. Jolly mentioned further that the presentation of a pilot project is the intention. This process would then critically highlight several pros and cons regarding the matter at hand.

As mentioned in the Las Vegas Sun, both the Las Vegas City Council and the Clark County commission have taken a ‘wait-and-see approach’, this being the first notable time that any timeframe of the endeavor had been given. As the situation currently stands, industry advocates have had their eyes on public lounges for consumption since the start of recreational sales last July. It is with the notion of over 40 million tourists entering Nevada each year, with the restrictions on cannabis consumption severely limiting use within hotels and casinos.

The Clark County Commission is currently planning to wait on public consumption of marijuana until the 2019 state legislature meetings. Chris Giunchigliani, county commissioner, urged that his group first wants to monitor the social use implementation in Denver prior to any decisions on their part (http://cnw.fm/eF4sX).

State Senator Tick Segerblom put forth his disappointment in that his vision of Las Vegas being the first major city within the United States to open marijuana lounges did not come to fruition. The step taken by Denver was noted to be a step forward, with the potential of benefiting Nevada. A further step forward would see the allowance of smoking the substance within lounges, with consumers not necessarily being restricted to consuming edible products, vaping and dabbing, as is the case in Colorado. It is with great anticipation that Las Vegas is awaiting the 2019 legislature meetings to prove successful within the recreational cannabis consumption industry.

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Marijuana Company of America, Inc. (MCOA) Creating a Diversified Range of Synergistic Opportunities in Hemp Sector

MCOA is involved in the production and distribution of high quality hemp-derived CBD products
Company continues to add high-demand retail products
Strategic investments and joint ventures offer broad-based opportunities

In spite of all of the short-term political gyrations, the cannabis and hemp markets continue to bloom. The demand for cannabidiol (CBD) products remains persistent, and there are many attractive opportunities in the sector. Marijuana Company of America, Inc. (OTC: MCOA) is in position to thrive in spite of any short-term contortions in the cannabis and hemp markets. The company’s low-risk, high-return profile results from its focus on industrial hemp-based CBD products and its portfolio of synergistic companies that operate in the space. MCOA has already undertaken multiple initiatives, building a portfolio of investments and joint ventures in the space.

MCOA recently invested $100,000 into Convenient Hemp Mart, LLC’s Benihemp-branded CBD product line for a 25 percent equity interest in Convenient Hemp Mart, LLC. BeniHemp products include topicals, tinctures and edibles, conveniently packaged in one-day, two-day and 30-day supplies. The target markets for these products are convenience stores, smoke shops, gas stations and similar types of small retail businesses where CBD commerce has significant potential to generate sales from the impulse buyer at the register. Convenient Hemp Mart officially launched the Benihemp product line at ASD Market Week (www.ASDOnline.com) in Las Vegas, Nevada, which took place from March 11-14. The trade show hosted 45,000 buyers from over 90 countries, representing major department stores, convenience stores, gift shops, grocery stores and other retail outlets.

Visit the Convenient Hemp Mart, LLC website at www.ConvenientHemp.com

Marijuana Company of America’s other line of hemp-based CBD consumer products is researched, developed and sold via an affiliate marketing model under the brand name hempSMART™. hempSMART™ sells a variety of wellness products on its website, including full spectrum bioavailable CBD drops, pain capsules with a blend of premium CBD and botanical supplements, pain cream and the latest new product targeting the booming $70 billion pet care market, hempSMART Full Spectrum Pet Drops. MCOA utilizes a unique hempSMART affiliate network-marketing program to promote and sell its hemp-based CBD consumer products.

In conjunction with joint venture partner Global Hemp Group Inc. (OTC: GBHPF), MCOA successfully cultivated industrial hemp during the 2017 growing season. For this phase of the project, hemp was grown for research purposes, as this was the first time in 20 years that industrial hemp was grown in northeast New Brunswick. The joint venture partners are now focusing on the next season of crops. Farmers have been recruited, and a minimum of 125 acres of hemp cultivation is planned for 2018, with the goal of increasing the acreage under cultivation to 1,000 acres by year three of the project. This first commercial crop will focus on CBD extraction. In addition, discussions are underway regarding the purchase of extraction equipment for cannabinoids and straw processing equipment for building materials. The companies expect the facilities to be in place and operational for the 2018 harvest in October.

In a joint venture with Bougainville Ventures Inc., MCOA further expanded its portfolio by completing financing of $800,000 in cash and 15 million shares of the company’s common stock, in full satisfaction of the amended agreement, to begin construction of a turnkey 30,000 sq. ft. state-of-the art agricultural cultivation and processing facility in Oroville, Washington. The turnkey facility will accommodate Bougainville’s contracted cannabis production and processing tenant with an approved Tier 3, I-502 license.

Marijuana Company of America’s diversified business plan is rapidly creating a broad range of opportunities with synergistic companies, positioning the company well into the future.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Compensation Disclosure

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Details Cannabis Exportation Agreement for Sol-gel Research

Permits obtained for importation of cannabis into Australia
PreveCeutical conducting research at University of Queensland for cannabinoid-based Sol-gel products
Cannabis-based Sol-gel products targeted at relieving symptoms such as pain, inflammation, seizures and neurological disorders

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), a health sciences company aiming to become a preventive health sciences leader, has announced the grant of three permits from the Australian government’s Department of Health allowing for the importation of cannabis into Australia for purposes of research. The permits, which have been granted to the Pharmacy Australia Centre of Excellence (PACE) at the University of Queensland, will allow PACE to import cannabis plant material shipments for research purposes. Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (FSE: 21P) (WKN: A1C4WM) will export the cannabis to PACE and has obtained the necessary Canadian permits to do so. Once shipped by Aurora, the cannabis will be used in PreveCeutical’s drug delivery research program for its Sol-gel (soluble gel).

The Sol-gel drug delivery research program, which is being undertaken at the University of Queensland, targets the development of a system that will enhance the bioavailability of drugs using a nose-to-brain delivery system. The program is being conducted by PreveCeutical’s research partner, UniQuest Pty Inc., and is being led by PreveCeutical Chief Research Officer Dr. Harendra Parekh.

The intention of PreveCeutical is to apply its Sol-gel technology to cannabinoids for the development of therapies to relieve a variety of symptoms, including pain, inflammation, seizures and neurological disorders. The permits obtained by PACE will allow PreveCeutical to test various cannabis strains for the development and commercialization of cannabinoid-based Sol-gels. Sol-gels boast a variety of advantages over traditional liquid nasal sprays, offering longer therapeutic effects, lower dosage requirements and a reduction in irritation and other unwanted side effects.

In consideration of its cannabis shipment for the research program, Aurora Cannabis has been granted certain rights, including an option to either license (on a nonexclusive basis) the Sol-gel technology for Canada and Australia or to choose a royalty arrangement on product sales, along with an option to purchase PreveCeutical shares. Part of Aurora’s strategy in becoming involved with PreveCeutical’s initiatives is gaining access to cannabis-based products that are more narrowly targeted at specific therapeutic areas but with a higher value add.

For more information, visit the company’s website at www.PreveCeutical.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Aims to Generate up to 80% of Revenues from Technology Licensing

CEO Chris Bunka says in audio interview that human study of company’s proprietary TurboCBD technology will start in April outside of North America
Hopes to add 6-12 more IP technology licensing contracts within year
Cutting-edge research designed to attract the attention of tobacco and cannabis industries

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent audio interview that, although consumer products will always be important to LXRP, he estimates that up to 80 percent of its revenues could be generated through the licensing of its proprietary technology to other companies (http://cnw.fm/yT2HS).

LXRP is a British Columbia, Canada-based bioscience company that is a drug delivery platform innovator. The company has developed its patented DehydraTECH™ delivery technology platform, which it out-licenses to promote healthier ingestion methods and lower overall dosing.

Bunka said that LXRP believes that 6-12 more licensing contracts will be signed this year, both generating more revenue for the company and building greater shareholder value. “We’ve only just graduated from the demonstration phase,” he explained in the interview.

“The latest contracts are typically six figure contracts in the first year and potentially seven figure contracts over the life of the contracts,” Bunka added. “They’re becoming bigger.” The company sees a potential game changer for itself in three new sets of studies and believes that each could be material to the valuation of the company.

The first is a completed study of the company’s proprietary DehydraTECH in the form of a topical cream for the absorption of cannabidiol (CBD) through human skin (http://cnw.fm/Lc5dU). LXRP said that results showed significant increases in quantity and speed of CBD absorption through the skin when compared to other formulations.

The second is a lab animal study that tests nicotine absorption. Using lab rats, the study measures gastrointestinal distress (http://cnw.fm/d7uXC). It will take blood and tissue samples at pre-prescribed time intervals to measure nicotine absorption. It will test LXRP’s ‘Trojan horse’ technology that may hide it from a negative response triggered by the body, Bunka said. An end goal is to bypass liver absorption and help avoid kidney and liver diseases associated with some of these substances by using LXRP technologies.

The third is a clinical human study first started with a Canadian University. Now, it has been moved out of North America into another institution, and the study’s initiation is imminent, he added. The study is on the cardiovascular and health effects of the company’s TurboCBD™ (http://cnw.fm/e6HIm). Bunka at the time said that the study would permit LXRP to custom design products that would increase the performance its technology already offers to customers.

“That study is now back on track. We expect it to begin in the month of April in a different location,” Bunka noted.

He added that all three studies, or any one of them, could mean a major change for the company, as its IP and studies attract increased interest from both the tobacco and cannabis industries. Lexaria has developed cutting-edge technologies with commercial application, he said in the interview.

“Those three studies, each one of those, has the potential to be a real game changer in the valuation of the company,” Bunka said.

For more information, visit the company’s website at www.LexariaBioscience.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Readies Niche Products for Legal Cannabis Industry

Spending on legal cannabis worldwide expected to hit $57 billion by 2027
Canadian government preparing to legalize cannabis-infused edibles and beverages by mid-2019
Investments into cannabis-related companies topped $1.2 billion over first five weeks of 2018

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis Compliance Inc. (“CCI”) to establish Good Manufacturing Practice (GMP)-compliant processes and procedures in producing its finished products (http://cnw.fm/k9W56).

“We are extremely excited to be working with CCI in establishing GMP manufacturing capabilities in-house,” Robert Jackman, scientific project manager/fulfillment for Liberty Leaf, stated in a news release. “This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the manufacture and sale of a wide range of medicinal-quality products for both human and veterinary use – not just cannabis and cannabis-containing finished products.”

According to Arcview Market Research and its research partner BDS Analytics, spending on legal cannabis worldwide is projected to hit $57 billion by 2027, as noted in an article published by Forbes (http://cnw.fm/88xXT). The adult-use recreational market is expected to generate 67 percent of those dollars, with medical marijuana taking up the remaining 33 percent. Cannabis buyers in North America, who are currently spending a little more than $9 billion, are expected to lay down $47.3 billion by 2027, the article states.

In Canada, the government’s decision to legalize recreational cannabis for adult users by mid-2018 will soon be followed by the prospect of additional profits in cannabis-infused edibles and beverages as these items become legal in the summer of 2019 (http://cnw.fm/pc0xM). Medical cannabis has been legal in Canada since 2001. Allowing edibles and cannabis-infused beverages is expected to generate an exceptional amount of interest from the public, according to a recent survey by Dalhousie University, a public research university in Canada.

“Curiosity seems to be driving consumers to want to try a food product, an edible, and the number one choice is bakery goods,” Dr. Sylvain Charlebois, the study’s lead author, said in an interview with CTVNews.ca (http://cnw.fm/V8FKk). The survey of 1,087 people found that 46 percent of Canadians would try cannabis-infused food products such as baked goods, oils and spices if they were commercially available.

Liberty Leaf President and Director William Rascan said that working with Cannabis Compliance to meet Canada’s strict GMP requirements for commercial production ensures that North Road will consistently manufacture safe, high quality finished cannabis-related products. North Road’s distribution strategy also includes a unique approach not yet seen in the cannabis industry, Rascan added.

“North Road plans to make available to both pharmacies and licensed retailers our exclusive medicinal-quality cannabis, cannabis-related products and racking jobber service,” Rascan said. “The ability for us to expand on our model by including Natural Health Products (NHPs) for human and veterinary use as well as cosmetics/beauty products, topicals, concentrates, foods/edibles and other high-quality products for distribution holds tremendous growth potential for our company.”

Investors continue to seek out and support cannabis companies – to the tune of more than $2.1 billion over the first five weeks of 2018, according to the Viridian Cannabis Deal Tracker, which tracks capital raises and M&A activity in the cannabis industry (http://cnw.fm/o7l4L). The demand for medical, recreational and cannabis-infused products is projected to continue its upward trajectory as more states in the U.S. begin to legalize some aspect of the highly regulated plant and Canada’s new laws take effect (http://cnw.fm/0hZMx).

For more information, visit the company’s website at www.LibLeaf.ca

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Continues to Advance its Agenda

Owns worldwide rights for patented formulations and drug delivery technologies
Develops and commercializes therapeutic pharmaceuticals and nutraceuticals
Strategic agenda to become one of world’s only vertically integrated cannabis biotechs

With worldwide rights for unique drug delivery platforms in place, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is rapidly building a disruptive, vertically integrated biotechnology company. Advancing this agenda, the company recently announced that it has retained Cannabis Compliance Inc. to submit an application to Health Canada for a dealer’s license on behalf of Pivot’s acquisition target, Agro-Biotech Inc. (http://cnw.fm/0K5Xn).

In February, Pivot announced that its entry into a letter of intent for the proposed acquisition of licensed cannabis producer Agro-Biotech (http://cnw.fm/cvP6W), which operates a fully licensed indoor hydroponic cannabis production facility that’s on track to expand its capacity 10,000 kg per year by the end of this year. Upon completion of the proposed acquisition, the dealer’s license will enable Pivot (through Agro-Biotech) to conduct research and store cannabis derivatives that are not currently covered under the Access to Cannabis for Medical Purposes Regulations.

With the acquisition of Agro-Biotech, Pivot Pharmaceuticals will control the entire manufacturing process from seed to medical derivatives and capture margins along the entire supply chain. The dealer’s license will move Pivot another step closer to becoming one of the only vertically integrated cannabis biotech companies in the world. Pivot is already a differentiated player in the Canadian cannabis industry with its unique approach to enhanced dosing and bioavailability of cannabinoids, and the company’s position in the market will only be bolstered by the acquisition.

Pivot Pharmaceuticals has assembled cutting-edge drug delivery technologies that assist both effectiveness and efficacy of medicinal cannabinoids and have potential applications across other drug categories. Pivot’s patent pending topical transdermal drug delivery technology platform, BiPhasix™, has been shown to significantly enhance the bioavailability of various drugs, leading to improved clinical outcomes. The company also acquired worldwide rights to Solmic Solubilisation Technology Platform, which allows active ingredients to become water-soluble without changing their composition or nature, significantly enhancing drug uptake.

With proven pharmaceutical and patented formulation and delivery technologies, Pivot is well positioned in an important, growing vertical of the cannabis industry and represents a compelling opportunity in the biotechnology sector. This latest announcement by Pivot enhances the opportunity.

For more information, visit the company’s website at www.PivotPharma.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net